BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19778817)

  • 1. [Reversion transcriptional expression of DAPK in bladder cancer T24 cells 5-aza-2'-deoxycytidine].
    Xu NR; Liu CX; Zheng SB; Li HL; Xu YW; Xu K
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1882-6. PubMed ID: 19778817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
    Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
    Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
    Zhang H; Qi F; Cao Y; Zu X; Chen M; Li Z; Qi L
    Cancer Biother Radiopharm; 2013 May; 28(4):343-50. PubMed ID: 23570371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.
    Christoph F; Kempkensteffen C; Weikert S; Köllermann J; Krause H; Miller K; Schostak M; Schrader M
    Br J Cancer; 2006 Dec; 95(12):1701-7. PubMed ID: 17133271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of 5-Aza-2'-deoxycytidine on human nasopharyngeal carcinoma xenograft in nude mice].
    Zhang S; Kong WJ; Wang YJ; Han YC; Zhang D
    Ai Zheng; 2005 Oct; 24(10):1201-5. PubMed ID: 16219133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells.
    Tanaka T; Bai T; Toujima S; Utsunomiya T; Matsuoka T; Kobayashi A; Yamamoto M; Sasaki N; Tanizaki Y; Utsunomiya H; Tanaka J; Yukawa K
    Oncol Rep; 2012 Apr; 27(4):1292-8. PubMed ID: 22246465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
    Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
    Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells.
    Yang B; Yang ZG; Gao B; Shao GG; Li GH
    Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.
    Su Y; Xu H; Xu Y; Yu J; Xian Y; Luo Q
    Hematology; 2012 Jan; 17(1):41-6. PubMed ID: 22549447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
    Bai T; Tanaka T; Yukawa K; Umesaki N
    Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
    Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients.
    Ye M; Li D; Zhou F; Guo Q; Xia B
    Eur J Cancer Prev; 2012 May; 21(3):241-6. PubMed ID: 21979297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer.
    Christoph F; Hinz S; Kempkensteffen C; Weikert S; Krause H; Schostak M; Schrader M; Miller K
    J Cancer Res Clin Oncol; 2007 Jun; 133(6):343-9. PubMed ID: 17160380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-aza-2'-deoxycytidine induces changes of histone H3-lysine 9 methylation in bladder tumor cells].
    Yang N; Li Z
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2295-8. PubMed ID: 19087683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.
    Leung RC; Liu SS; Chan KY; Tam KF; Chan KL; Wong LC; Ngan HY
    Oncol Rep; 2008 May; 19(5):1339-45. PubMed ID: 18425396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
    Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
    Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
    Zuo S; Chen Y; Xu L; Tang Q; Zou S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.
    Liu X; Dai X; Wu B
    Urol Int; 2009; 82(1):108-12. PubMed ID: 19172108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.